PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Methotrexate
Presentation Product Chemical substance Chapter Items dispensed
Methotrexate 2.5mg tablets
1001030U0AAABAB
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 176,059
Metoject PEN 20mg/0.4ml inj pre-filled pens
1001030U0BEARBW
Metoject (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 25,425
Metoject PEN 25mg/0.5ml inj pre-filled pens
1001030U0BEAWCB
Metoject (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 18,503
Metoject PEN 15mg/0.3ml inj pre-filled pens
1001030U0BEAXCC
Metoject (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 17,726
Metoject PEN 10mg/0.2ml inj pre-filled pens
1001030U0BEAZCE
Metoject (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 7,524
Metoject PEN 17.5mg/0.35ml inj pre-filled pens
1001030U0BEAQBV
Metoject (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 4,908
Methotrexate 20mg/0.4ml inj pre-filled disposable devices
1001030U0AABWBW
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 4,326
Metoject PEN 12.5mg/0.25ml inj pre-filled pens
1001030U0BEAYCD
Metoject (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 4,123
Methotrexate 10mg tablets
1001030U0AAACAC
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 3,448
Nordimet 20mg/0.8ml solution for injection pre-filled pens
0801030P0BFAFFS
Nordimet Methotrexate Malignant Disease and Immunosuppression 3,207
Methotrexate 15mg/0.3ml inj pre-filled disposable devices
1001030U0AACCCC
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 3,057
Metoject PEN 22.5mg/0.45ml inj pre-filled pens
1001030U0BEASBX
Metoject (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 2,976
Methotrexate 25mg/0.5ml inj pre-filled disposable devices
1001030U0AACBCB
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 2,776
Nordimet 15mg/0.6ml solution for injection pre-filled pens
0801030P0BFADFQ
Nordimet Methotrexate Malignant Disease and Immunosuppression 2,491
Metoject PEN 7.5mg/0.15ml inj pre-filled pens
1001030U0BEATBY
Metoject (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 2,476
Nordimet 25mg/1ml solution for injection pre-filled pens
0801030P0BFAHFU
Nordimet Methotrexate Malignant Disease and Immunosuppression 1,773
Methotrexate 10mg/0.2ml inj pre-filled disposable devices
1001030U0AACECE
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 1,370
Methotrexate 20mg/0.4ml inj pre-filled syringes
1001030U0AABHBH
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 1,171
Nordimet 10mg/0.4ml solution for injection pre-filled pens
0801030P0BFABFN
Nordimet Methotrexate Malignant Disease and Immunosuppression 993
Methotrexate 15mg/0.3ml inj pre-filled syringes
1001030U0AABGBG
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 942
Methofill 20mg/0.4ml inj pre-filled injector
1001030U0BGAFBW
Methofill (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 823
Methotrexate 17.5mg/0.35ml inj pre-filled disposable devices
1001030U0AABVBV
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 750
Maxtrex 2.5mg tablets
1001030U0BDAAAB
Maxtrex (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 597
Methotrexate 12.5mg/0.25ml inj pre-filled disposable devices
1001030U0AACDCD
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 589
Methotrexate 25mg/0.5ml inj pre-filled syringes
1001030U0AABIBI
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases 585

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.